References
- Bodor N. Novel approaches to the design of safer drugs: soft drugs and site-specific chemical delivery systems. Advances in Drug Research. Academic Press, LondonUK 1984; Volume 13: 255–331
- Bodor N. Soft drug principles and methods for the design of safer drugs. Med. Res. Rev. 1984; 4: 449–465
- Druzgala P., Hochhaus G., Bodor N. Soft drugs-10. Blanching activity and receptor binding activity of a new type of glucocorticoid: loteprednol etabonate. J. Steroid Biochem. Molec. Biol. 1991; 38: 149–154
- Chang T. C., Lee V. H.L. Influence of chain length on the in vitro hydrolysis of model ester prodrugs by ocular esterases. Curr. Eye Res. 1983; 2: 651–656
- Bodor N., Visor G. Formation of adrenaline in the iris-ciliary body from adrenalone diesters. Exp. Eye Res. 1984; 38: 621–626
- Lee V. H. L. Esterase activities in adult rabbit eyes. J. Pharm. Sci. 1983; 72: 239–244
- Lee V. H. L., Morimoto K. W., Stratford R. E., Jr. Esterase distribution in the rabbit cornea and its implication in ocular drug bioavailability. Biopharm. and Drug Dispos. 1982; 3: 291–300